No responses to oral etoposide in 15 patients with recurrent brain tumors
- 29 June 2000
- journal article
- research article
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 35 (1) , 80-82
- https://doi.org/10.1002/1096-911x(200007)35:1<80::aid-mpo15>3.0.co;2-z
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Phase II study of daily oral etoposide in children with recurrent brain tumors and other solid tumorsMedical and Pediatric Oncology, 1997
- Recurrent Cerebellar Gliomas: Salvage Therapy With Oral EtoposideJournal of Child Neurology, 1997
- Response of recurrent medulloblastoma to low-dose oral etoposide.Journal of Clinical Oncology, 1996
- Phase I study of oral etoposide in children with refractory solid tumors.Journal of Clinical Oncology, 1994
- Protracted oral etoposide in epithelial ovarian cancer: a phase II study in patients with relapsed or platinum-resistant diseaseBritish Journal of Cancer, 1994
- Recurrent brainstem gliomas treated with oral VP-16Journal of Neuro-Oncology, 1993
- Chronic Administration of Etoposide in the Treatment of Non-Hodgkin's LymphomaLeukemia & Lymphoma, 1993
- Prolonged administration of oral etoposide in non-small-cell lung cancer: a phase II trial.Journal of Clinical Oncology, 1992
- Penetration of etoposide into human malignant brain tumors after intravenous and oral administrationCancer Chemotherapy and Pharmacology, 1992
- Etoposide (VP-16-213) in malignant brain tumors: a phase II study.Journal of Clinical Oncology, 1984